Lemaitre Vascular (LMAT) Tops Q4 EPS by 2c, provides guidance
Tweet
Share
E-mailGet Alerts LMAT Hot Sheet
Price: $80.59 +2.27%
Revenue Growth %: +11.0%
Financial Fact:
Research and development: 1.54M
Today's EPS Names:
ANAB, ANIX, MNY, More
Revenue Growth %: +11.0%
Financial Fact:
Research and development: 1.54M
Today's EPS Names:
ANAB, ANIX, MNY, More
Join SI Premium – FREE
Lemaitre Vascular (NASDAQ: LMAT) reported Q4 EPS of $0.68, $0.02 better than the analyst estimate of $0.66. Revenue for the quarter came in at $64.45 million versus the consensus estimate of $62.98 million.
GUIDANCE:
Lemaitre Vascular sees Q1 2026 revenue of $65.6-67.6 million, versus the consensus of $65.85 million.
Lemaitre Vascular sees FY2026 revenue of $276-284 million, versus the consensus of $270.5 million.
For earnings history and earnings-related data on Lemaitre Vascular (LMAT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Corning (GLW) files for up to $2B offering of common shares
- EagleOne Metals closes $225,199 non-brokered private placement
- RH (RH) Tops Q2 EPS by $2.31
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
